Drug Database
Back to search

Poland· PL-100302666

Koenzym Q10 forte

A ubidecarenone product containing ubidecarenonum, registered in Poland by Przedsiębiorstwo Produkcji Farmaceutycznej HASCO-LEK S.A.. The same ATC class is registered in 6 of our 19 countries.

ATC C01EB09

Checked against URPL (Poland) on

Informational only — not a medical device.

SOURCE REGISTER · PLURPL (Poland)normalisedKoenzym Q10 forteATCC01EB09REGISTER NO.PL-100302666PACKS LISTED2CHECKEDSeptember 27, 2026
Compare price across countriesPer daily dose · free accountAsk the assistant about ubidecarenonumAnswers with sources · free accountCheck interactionsSeverity free · mechanism on Growth

Where it is registered

Ubidecarenone is registered in 6 of 19 countries.

Countries holding a registration under ATC C01EB09 (ubidecarenone), each read from that country’s own register.

  • This record: Poland, from URPL (Poland)
  • 3 of them publish a price we can compare per daily dose
Search ubidecarenone products by name

Ubidecarenone · ATC C01EB09

6 / 19 countries

  • Denmark
  • Japan
  • Norwayprice
  • Polandprice
  • United Kingdom
  • United Statesprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

The record

At a glance

URPL (Poland)
Active substance
Ubidecarenonum
Manufacturer
Przedsiębiorstwo Produkcji Farmaceutycznej HASCO-LEK S.A.
Country
Poland (PL)
ATC code
C01EB09
ATC class
Ubidecarenone
Reimbursed
Not published by this register
Source register
URPL (Poland)
Last checked
September 27, 2026

Packs & prices · 2

  • gtin
    05909991080945
  • gtin
    05909991080952

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Same medicine, other countries

Ubidecarenone in 3 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All ubidecarenone products

Authorised across Europe · EMA

The same active substance is authorised in 5 EEA countries. Names it is sold under:

  • Denmark · Bio-Qinon Q10
  • Hungary · Myoqinon
  • Italy · Decorenone, Ubimaior
  • Latvia · Bio-Quinone Q10
  • Portugal · Q10, Q10 Forte

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of URPL (Poland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/dee00584-cff5-47d8-a849-ee6e0269502e
GET /v1/drugs/dee00584-cff5-47d8-a849-ee6e0269502e?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "form": "Kapsułki miękkie",
  "source": "urpl",
  "strength": "100 mg",
  "packaging": "05909991080945 ¦ OTC ¦ 86128\n30 kaps.\n05909991080952 ¦ OTC ¦ 86129\n60 kaps.",
  "substance": "Ubidecarenonum 100 mg",
  "common_name": "Ubidecarenonum",
  "pl_product_id": "100302666",
  "pozwolenie_nr": "21417",
  "auth_procedure": "NAR",
  "authorisation_validity": "2018-08-28"
}
API referenceMCP serverPlans

See everything about ubidecarenone.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.

Try it freeOpen in the console